These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25369302)

  • 21. Current treatment for hepatocellular carcinoma.
    Cahill BA; Braccia D
    Clin J Oncol Nurs; 2004 Aug; 8(4):393-9. PubMed ID: 15354926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.
    Manini MA; Sangiovanni A; Fornari F; Piscaglia F; Biolato M; Fanigliulo L; Ravaldi E; Grieco A; Colombo M;
    J Hepatol; 2014 May; 60(5):995-1001. PubMed ID: 24462368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of the clinical practice guidelines for hepatocellular carcinoma in Japan and Western countries].
    Ikai I
    Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):343-8. PubMed ID: 19068716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The current status of imaging diagnosis of hepatocellular carcinoma.
    Choi BI
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S20-5. PubMed ID: 14762834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
    Dhanasekaran R; Khanna V; Kooby DA; Spivey JR; Parekh S; Knechtle SJ; Carew JD; Kauh JS; Kim HS
    J Vasc Interv Radiol; 2010 Aug; 21(8):1197-204; quiz 204. PubMed ID: 20656222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and multimodal therapy for hepatocellular carcinoma].
    Kolligs FT; Hoffmann RT; op den Winkel M; Bruns CJ; Herrmann K; Jakobs TF; Lamerz R; Trumm C; Zech CJ; Wilkowski R; Graeb C
    Z Gastroenterol; 2010 Feb; 48(2):274-88. PubMed ID: 20119895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiological biomarkers for assessing response to locoregional therapies in hepatocellular carcinoma: From morphological to functional imaging (Review).
    Ye XD; Yuan Z; Zhang J; Yuan Z
    Oncol Rep; 2017 Mar; 37(3):1337-1346. PubMed ID: 28184942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT and MR imaging of hepatocellular carcinoma.
    Bolog N; Andreisek G; Oancea I; Mangrau A
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):181-9. PubMed ID: 21725516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CT and MRI of hepatocellular carcinoma: an update.
    Ayyappan AP; Jhaveri KS
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):507-19. PubMed ID: 20397916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete tumor encapsulation on magnetic resonance imaging: a potentially useful imaging biomarker for better survival in solitary large hepatocellular carcinoma.
    Lu DS; Siripongsakun S; Kyong Lee J; Wei SH; Cheng PM; Sabounchi S; Lee JS; Raman S; Tong MJ; Busuttil RW; Sayre J
    Liver Transpl; 2013 Mar; 19(3):283-91. PubMed ID: 23280814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.
    Willatt JM; Hussain HK; Adusumilli S; Marrero JA
    Radiology; 2008 May; 247(2):311-30. PubMed ID: 18430871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiological evaluation of the therapeutic response of malignant diseases: status quo, innovative developments and requirements for radiology.
    Höink AJ; Heindel W; Buerke B
    Rofo; 2014 Oct; 186(10):927-36. PubMed ID: 25122173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of hepatocellular carcinoma.
    El-Serag HB; Marrero JA; Rudolph L; Reddy KR
    Gastroenterology; 2008 May; 134(6):1752-63. PubMed ID: 18471552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The diagnostic approach to hepatocellular carcinoma].
    Schacherer D; Schoelmerich J; Zuber-Jerger I
    Z Gastroenterol; 2007 Oct; 45(10):1067-74. PubMed ID: 17924305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of imaging in hepatocellular carcinoma: the present and future.
    Davarpanah AH; Weinreb JC
    J Clin Gastroenterol; 2013 Jul; 47 Suppl():S7-10. PubMed ID: 23632342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early hepatocellular carcinoma: pathology, imaging, and therapy.
    Takayama T; Makuuchi M; Kojiro M; Lauwers GY; Adams RB; Wilson SR; Jang HJ; Charnsangavej C; Taouli B
    Ann Surg Oncol; 2008 Apr; 15(4):972-8. PubMed ID: 18236118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know.
    Tang A; Valasek MA; Sirlin CB
    Adv Anat Pathol; 2015 Sep; 22(5):314-22. PubMed ID: 26262514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances of imaging for hepatocellular carcinoma.
    Choi BI
    Oncology; 2010 Jul; 78 Suppl 1():46-52. PubMed ID: 20616584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011.
    Song P; Tobe RG; Inagaki Y; Kokudo N; Hasegawa K; Sugawara Y; Tang W
    Liver Int; 2012 Aug; 32(7):1053-63. PubMed ID: 22432445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.